B-701, a selective and potent inhibitor of fibroblast growth factor receptor 3 (FGFR3), may enhance the activity of bladder cancer therapies

2016 ◽  
Vol 69 ◽  
pp. S20 ◽  
Author(s):  
J. Holash ◽  
K. Schwartz ◽  
S. Lau
Oncogene ◽  
1999 ◽  
Vol 18 (51) ◽  
pp. 7234-7243 ◽  
Author(s):  
David Ricol ◽  
David Cappellen ◽  
Ahmed El Marjou ◽  
Sixtina Gil-Diez-de-Medina ◽  
Jeanne-Marie Girault ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document